Chen Fu
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Inflammasome and immune disorders 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Shaojiao Liu (2 shared papers)Xuemei Liu (2 shared papers)Zhang Yunling (2 shared papers)Ling‐Feng Wang (1 shared paper)Menghan Liu (1 shared paper)Yifan Wu (1 shared paper)Hong Zheng (7 shared papers)Bi‐Cheng Wang (5 shared papers)
- Journals
- Medicine (2 papers)Cancer Medicine (2 papers)International Journal of Environmental Research and Public Health (1 paper)Frontiers in Pharmacology (1 paper)Metabolic Syndrome and Related Disorders (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chen Fu
28 papers receiving 631 citations
Chen Fu's Hit Papers
Peers
Comparison fields: 5 of 85
- Neurology 79
- Cancer Research 116
- Complementary and alternative medicine 49
- Pulmonary and Respiratory Medicine 149
- Otorhinolaryngology 15
Countries citing papers authored by Chen Fu
This map shows the geographic impact of Chen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Fu more than expected).
Fields of papers citing papers by Chen Fu
This network shows the impact of papers produced by Chen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Fu. The network helps show where Chen Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia Hit paper breakdown → | 2022 | 257 |
| 2 | 2020 | 64 | |
| 3 | 2017 | 37 | |
| 4 | 2019 | 30 | |
| 5 | 2019 | 25 | |
| 6 | 2017 | 22 | |
| 7 | 2021 | 19 | |
| 8 | 2017 | 19 | |
| 9 | 2016 | 19 | |
| 10 | 2020 | 17 | |
| 11 | 2017 | 16 | |
| 12 | 2019 | 15 | |
| 13 | 2017 | 13 | |
| 14 | 2022 | 12 | |
| 15 | 2022 | 11 | |
| 16 | 2024 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2023 | 6 |
About Chen Fu
Chen Fu is a scholar working on Molecular Biology, Oncology, Psychiatry and Mental health, Epidemiology and Otorhinolaryngology, having authored 30 papers that have together received 639 indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (5 papers), Head and Neck Cancer Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Colorectal Cancer Screening and Detection (2 papers), Traditional Chinese Medicine Studies (2 papers), Inflammasome and immune disorders (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Neurology (79 citations), Cancer Research (116 citations), Complementary and alternative medicine (49 citations), Pulmonary and Respiratory Medicine (149 citations) and Otorhinolaryngology (15 citations). Chen Fu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shaojiao Liu, Xuemei Liu, Zhang Yunling, Ling‐Feng Wang, Menghan Liu, Yifan Wu, Hong Zheng, Bi‐Cheng Wang, Fengli Wang and Baoxin Chen. Their work appears in journals such as Medicine, Cancer Medicine, International Journal of Environmental Research and Public Health, Frontiers in Pharmacology and Metabolic Syndrome and Related Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.